← Back to Search

Storytelling Therapy for Mental Health Wellness in Sexual and Gender Minority Adults (SEEN Trial)

N/A
Waitlist Available
Led By Jennifer Tran, PhD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

SEEN Trial Summary

This trial will examine if telling your story through photos/videos can improve the mental health of emerging adults of color who identify as a member of a sexual/gender minority.

Who is the study for?
This trial is for sexual and gender minority emerging adults of color, aged 18-24, living in the Philadelphia area. Participants must have moderate to severe depression without recent suicidal ideation and access to a smartphone or computer. Cisgender heterosexual individuals, non-Hispanic whites, those outside the age range or region, with mild depression or unmanaged psychotic disorders are excluded.Check my eligibility
What is being tested?
The study tests if Critical Narrative Interventions (CNIs), like sharing personal stories through photos or videos, can improve mental health outcomes such as depression and self-esteem in young adults who are both racial/ethnic and sexual/gender minorities. Participants will be randomly assigned to use either photographs or video narratives.See study design
What are the potential side effects?
There may not be direct physical side effects from participating; however, discussing sensitive topics could potentially lead to emotional discomfort. Support will be provided for any distress caused by sharing personal experiences.

SEEN Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Generalized Anxiety Disorder-7 (GAD-7)
Patient Health Questionnaire (PHQ-9)
Rosenberg Self-Esteem Scale
+1 more
Secondary outcome measures
Attitudes Toward Mental Health Treatment (ATMHT) scale
General Belongingness Scale (GBS)
Internalized Stigma of Mental Illness Scale (ISMI-9)
+4 more
Other outcome measures
Acceptability of the Intervention Measure (AIM)
Feasibility of the Intervention Measure (FIM)
Intervention Appropriateness of the Measure (IAM)

SEEN Trial Design

2Treatment groups
Experimental Treatment
Group I: Photo-NovellaExperimental Treatment1 Intervention
Participants in the photo-novella intervention will be asked to take 12 photographs and write a caption for each photo based on two prompts.
Group II: Digital StorytellingExperimental Treatment1 Intervention
Participants in the digital storytelling intervention will be asked to create two videos (1-3 minutes each) based on two prompts.

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,000 Previous Clinical Trials
42,880,068 Total Patients Enrolled
Jennifer Tran, PhDPrincipal InvestigatorUniversity of Pennsylvania

Media Library

Photo-Novella Clinical Trial Eligibility Overview. Trial Name: NCT05899218 — N/A
Sexual Orientation Research Study Groups: Photo-Novella, Digital Storytelling
Sexual Orientation Clinical Trial 2023: Photo-Novella Highlights & Side Effects. Trial Name: NCT05899218 — N/A
Photo-Novella 2023 Treatment Timeline for Medical Study. Trial Name: NCT05899218 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What outcome is this clinical trial hoping to achieve?

"The primary metric to be assessed throughout this 12-month trial is the Generalized Anxiety Disorder-7 (GAD-7). Additionally, participants will have their Multidimensional Scale of Perceived Social Support (MSPSS) scores measured. This score ranges from 1 to 7, with higher numbers indicating greater perceived social support. For Intersectional Discrimination Index -Anticipated Discrimination (InDI-A), a scale ranging from 0 to 4 ascertains anticipated intersectional discrimination; and finally, The Queer People of Color Identity Affirmation Scale (QPIAS) gauges both identity based growth on a 7–49 spectrum as well as"

Answered by AI

Is this research initiative looking for participants aged over 35?

"This clinical trial is actively enrolling individuals over the age of 18 and below 24."

Answered by AI

Are there any requirements for eligibility in this clinical venture?

"This clinical trial permits the enrollment of thirty individuals who identify as LGBTQIA+ and are between 18-24 years old."

Answered by AI

Are enrollments available for this medical study?

"This medical investigation, first listed on July 17th 2023 and recently revised on August 9th 2023, is not searching for applicants. Nevertheless, 45 other trials are currently admitting participants."

Answered by AI
~4 spots leftby Jul 2024